Una Galani is Associate Editor of Reuters Breakingviews, based in Mumbai. She covers a cross-section of business, finance, and politics in South Asia. Una was in Hong Kong from 2013 and previously spent three years in Dubai writing about Middle Eastern economies during the Arab Spring. She joined Breakingviews in 2006 in London. In 2016, she won Asia Pacific Best Editorial Comment at the State Street Press Awards and Reuters global analysis/commentary of the year. She read English Literature at St Catherine’s College, Oxford. Follow @ugalani
Unprofitable Zomato is charging higher delivery fees and cutting discounts. At the same time, the pandemic hasn’t catalysed fortunes for the Ant-backed firm the way it did for peers such as U.S.-based DoorDash. That makes a $5.4 bln valuation from February look stuffed full.
Shaking pandemic nightmares over the past week has been impossible as the virus begins to ebb in Mumbai but drowns Delhi and beyond. Watching the human misery is overwhelming but seeing the economic consequences even as billion dollar-plus deals get done is just as affecting.
The Serum Institute, the world’s top vaccine maker, is under heavy pressure, with owner Adar Poonawalla complaining of “unprecedented” threats from politicians and tycoons trying to secure jabs. India’s flawed procurement policy is straining fraught ties with the private sector.